Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Effectiveness of a Low Carbohydrate Diet Versus a High Carbohydrate Diet in Promoting Weight Loss and Improved Health [Phase 2]
This Phase 2 trial compares the effectiveness of a low-carbohydrate diet versus a high-carbohydrate diet for weight loss and health outcomes…
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Tadalafil Effects in Left Ventricle Diastolic Dysfunction in Resistant Hypertensive Patients [NA]
Clinical trial update indicating completed results for tadalafil in patients with resistant hypertension and left ventricular diastolic dysf…
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Influence of Respiratory Muscle Training in Elderly Hypertensive Women With Respiratory Muscle Weakness [NA]
A clinical trial evaluating respiratory muscle training in elderly women with hypertension and respiratory muscle weakness has completed.
-
FDA approval · 2012-12-05FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for Macleods Pharmaceuticals Limited to market Irbesartan and Hydrochlorothiazide as a fixed-dos…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Diet and Whole-body Vibration Training on Cardiovascular and Autonomic Function [NA]
A completed clinical trial from Florida State University evaluated the effects of diet and whole-body vibration training on cardiovascular a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-12-05Clinical Trial Update: The Effects of Stretching Training on Arterial Function and Autonomic Control [NA]
A completed clinical trial from Florida State University evaluated whether stretching training affects arterial function and autonomic contr…
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Black Education and Treatment of Hypertension (BEAT HTN) [Phase 4]
Phase 4 BEAT HTN study, sponsored by Creighton University, has completed and posted results evaluating approaches to treating hypertension.
-
FDA approval · 2012-12-04FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Original Application (Mylan Pharmaceuticals Inc.)
The FDA approved an original ANDA for a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide by Mylan Pharmaceuticals Inc…
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition [Phase 1]
Completed Phase 1 bioequivalence study of Lisinopril 40 mg tablets under fed conditions conducted by IPCA Laboratories Ltd.
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients [Phase 4]
Open-label Phase 4 study assessing long-term safety of Caduet in Japanese patients completed; results posted in 2012.
-
FDA approval · 2012-11-30FDA Approved: FUROSEMIDE — Supplemental Application (Ipca Laboratories Limited)
The FDA approved a supplemental application for furosemide from Ipca Laboratories Limited, indicating approval of their generic furosemide p…
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension [Phase 4]
Phase 4 randomized study comparing bisoprolol and atenolol in adults with essential hypertension, assessing resting heart rate and sympathet…
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: Human Intestinal Amino Acid Absorption and the Role of a Local (Renin)-Angiotensin System (RAS)
A completed clinical trial from the University of Zurich explored how intestinal amino acid absorption is affected by a local renin-angioten…
-
FDA approval · 2012-11-28FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Exforge (amlodipine besylate and valsartan) from Novartis Pharmaceuticals Corporation. This acti…
-
FDA approval · 2012-11-28FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for EXFORGE HCT, a fixed-dose combination of amlodipine, valsartan, and hydrochlorothiazide, fil…
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: 10 Prescriptions an Hour. Group Treatment and Physical Activity Referral in a Primary Health Care Setting [NA]
A completed clinical trial evaluated the impact of group treatment plus a physical activity referral in a primary care setting for patients …
-
FDA approval · 2012-11-26FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approves a supplemental application for verapamil hydrochloride from Actavis Pharma, Inc. for an already authorized product.
-
CLINICAL_TRIALS research · 2012-11-22Clinical Trial Update: Using Learning Teams for Reflective Adaptation for Diabetes and Depression [NA]
A completed clinical trial evaluating the use of learning teams to support reflective adaptation in diabetes and depression care.
-
FDA label_change · 2012-11-16FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for NORVASC (amlodipine besylate) filed by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2012-11-16Clinical Trial Update: COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-i Treatment Due to couGH in Slovakia
A completed trial conducted in Slovakia evaluated cough in hypertensive patients treated with telmisartan who had stopped ACE inhibitors bec…
-
CLINICAL_TRIALS withdrawal · 2012-11-16Clinical Trial Update: Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic Patients [Phase 3]
A Phase 3 trial comparing Adalat XL to Diltiazem in hypertensive patients with diabetic nephropathy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-11-16Clinical Trial Update: Assessment of Compliance With Antihypertensive Telmisartan Therapy
This clinical trial update discusses patient compliance with telmisartan therapy for hypertension. The study, sponsored by Bayer, has comple…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: CKD-828 S-Amlodipine Non-Responder Trial [Phase 3]
Phase 3 trial update on CKD-828 S-Amlodipine for hypertension; the non-responder study has completed.
-
FDA approval · 2012-11-14FDA Approved: IRBESARTAN — Original Application (Chartwell RX, LLC)
The FDA approved Chartwell RX, LLC's original Abbreviated New Drug Application for irbesartan, enabling a generic version of the medication.
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: Beneficial Effects of Korean Traditional Diets in Subjects With Hypertension and Type 2 Diabetes [NA]
A completed clinical trial from Chonbuk National University Hospital reports beneficial effects of Korean traditional diets in people with h…